Sustained Delivery of a Heterodimer Bone Morphogenetic Protein-2/7 via a Collagen Hydroxyapatite Scaffold Accelerates and Improves Critical Femoral Defect Healing.

[1]  T. Yoshii,et al.  Hydroxyapatite/collagen composite graft for posterior lumbar interbody fusion: a comparison with local bone graft , 2021, Journal of Orthopaedic Surgery and Research.

[2]  F. O'Brien,et al.  Incorporation of hydroxyapatite into collagen scaffolds enhances the therapeutic efficacy of rhBMP-2 in a weight-bearing femoral defect model , 2021, Materials Today Communications.

[3]  P. Bourgine,et al.  Manufacturing of Human Tissues as off‐the‐Shelf Grafts Programmed to Induce Regeneration , 2021, Advanced materials.

[4]  M. Simionescu,et al.  Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice , 2021, Cell Death & Disease.

[5]  A. Schmidtchen,et al.  Peptide-coated polyurethane material reduces wound infection and inflammation. , 2021, Acta biomaterialia.

[6]  Jan Christian.  A tale of two receptors: Bmp heterodimers recruit two type I receptors but use the kinase activity of only one , 2021, Proceedings of the National Academy of Sciences.

[7]  Shawn C. Little,et al.  BMP heterodimers signal via distinct type I receptor class functions , 2021, Proceedings of the National Academy of Sciences.

[8]  H. Bunjes,et al.  Bone Morphogenetic Protein 2 (BMP-2) Aggregates Can be Solubilized by Albumin—Investigation of BMP-2 Aggregation by Light Scattering and Electrophoresis , 2020, Pharmaceutics.

[9]  L. Lidgren,et al.  A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein–2 and zoledronic acid , 2020, Science Advances.

[10]  D. Arens,et al.  The relation between fracture activity and bone healing with special reference to the early healing phase - A preclinical study. , 2020, Injury.

[11]  Brett S. Klosterhoff,et al.  Effects of osteogenic ambulatory mechanical stimulation on early stages of BMP-2 mediated bone repair , 2020, bioRxiv.

[12]  Gerry L. Koons,et al.  Materials design for bone-tissue engineering , 2020, Nature Reviews Materials.

[13]  S. Seno,et al.  In vivo dynamic analysis of BMP-2-induced ectopic bone formation , 2020, Scientific Reports.

[14]  M. Stoddart,et al.  Functional Biomaterials for Bone Regeneration: A Lesson in Complex Biology , 2020, Advanced Functional Materials.

[15]  R. Guldberg,et al.  Heparin-mediated delivery of bone morphogenetic protein-2 improves spatial localization of bone regeneration , 2020, Science Advances.

[16]  A. Schmidtchen,et al.  A dual-action peptide-containing hydrogel targets wound infection and inflammation , 2020, Science Translational Medicine.

[17]  Jie Song,et al.  Multifunctional scaffolds for facile implantation, spontaneous fixation, and accelerated long bone regeneration in rodents , 2019, Science Translational Medicine.

[18]  A. Turkiewicz,et al.  18F-fluoride as a prognostic indicator of bone regeneration. , 2019, Acta biomaterialia.

[19]  E. Alsberg,et al.  Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair , 2019, Science Advances.

[20]  L. Lidgren,et al.  Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery. , 2019, Biomaterials.

[21]  G. Schmidmaier,et al.  Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions. , 2018, Orthopaedics & traumatology, surgery & research : OTSR.

[22]  Peigang Cao,et al.  BMP2/7 heterodimer enhances osteogenic differentiation of rat BMSCs via ERK signaling compared with respective homodimers , 2018, Journal of cellular biochemistry.

[23]  P. Bourgine,et al.  Delivery of cellular factors to regulate bone healing , 2018, Advanced drug delivery reviews.

[24]  L. Lidgren,et al.  Gelatin‐ hydroxyapatite‐ calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein‐2 and zoledronic acid for increased bone formation: In‐vitro and in‐vivo carrier properties , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[25]  T. Yoshii,et al.  Augmentation of fracture healing by hydroxyapatite/collagen paste and bone morphogenetic protein‐2 evaluated using a rat femur osteotomy model , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  J. Alblas,et al.  Bone formation by heterodimers through non-viral gene delivery of BMP-2/6 and BMP-2/7. , 2018, European cells & materials.

[27]  H. Yoshikawa,et al.  BMP-2/7 heterodimer strongly induces bone regeneration in the absence of increased soft tissue inflammation. , 2018, The spine journal : official journal of the North American Spine Society.

[28]  R. Guldberg,et al.  Competitive Protein Binding Influences Heparin-Based Modulation of Spatial Growth Factor Delivery for Bone Regeneration. , 2017, Tissue engineering. Part A.

[29]  V. Agrawal,et al.  A review on carrier systems for bone morphogenetic protein-2. , 2017, Journal of biomedical materials research. Part B, Applied biomaterials.

[30]  M. Best,et al.  Acellular hydroxyapatite-collagen scaffolds support angiogenesis and osteogenic gene expression in an ectopic murine model: Effects of hydroxyapatite volume fraction. , 2016, Journal of biomedical materials research. Part A.

[31]  L. Lidgren,et al.  A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone , 2016, Scientific Reports.

[32]  Jia Shen,et al.  A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2. , 2016, Tissue engineering. Part B, Reviews.

[33]  N. Clement,et al.  The radiographic union scale in tibial (RUST) fractures , 2016, Bone & joint research.

[34]  F. O'Brien,et al.  Functionalization of a Collagen–Hydroxyapatite Scaffold with Osteostatin to Facilitate Enhanced Bone Regeneration , 2015, Advanced healthcare materials.

[35]  F. O'Brien,et al.  Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[36]  T. Kaito,et al.  The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model. , 2015, The spine journal : official journal of the North American Spine Society.

[37]  Robert J. Kane,et al.  Hydroxyapatite reinforced collagen scaffolds with improved architecture and mechanical properties. , 2015, Acta biomaterialia.

[38]  A. Kinaci,et al.  Trends in bone graft use in the United States. , 2014, Orthopedics.

[39]  Yoshinobu Watanabe,et al.  Establishment of reproducible, critical-sized, femoral segmental bone defects in rats. , 2014, Tissue engineering. Part C, Methods.

[40]  Andrés J. García,et al.  Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle. , 2014, Biomaterials.

[41]  Ivan Martin,et al.  Manufacturing Challenges in Regenerative Medicine , 2014, Science Translational Medicine.

[42]  L. Lohmander,et al.  An ARGS-aggrecan assay for analysis in blood and synovial fluid. , 2014, Osteoarthritis and cartilage.

[43]  F. O'Brien,et al.  Novel Microhydroxyapatite Particles in a Collagen Scaffold: A Bioactive Bone Void Filler? , 2014, Clinical orthopaedics and related research.

[44]  F. Dehghani,et al.  A sugar-based phase-transitioning delivery system for bone tissue engineering. , 2013, European cells & materials.

[45]  J. Buchowski,et al.  High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases. , 2013, The Journal of bone and joint surgery. American volume.

[46]  J. San Román,et al.  Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU-PLGA-βTCP concentric system in a critical size defect in rats. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[47]  K. Tsuchida,et al.  Osteogenic Differentiation Capacity of Human Skeletal Muscle-Derived Progenitor Cells , 2013, PloS one.

[48]  H. Okano,et al.  Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-α , 2012, Nature Protocols.

[49]  R. Guldberg,et al.  Effects of in vivo mechanical loading on large bone defect regeneration , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[50]  Michael N. Wosczyna,et al.  Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP‐dependent osteogenic activity and mediate heterotopic ossification , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  Andrés J. García,et al.  Effects of protein dose and delivery system on BMP-mediated bone regeneration. , 2011, Biomaterials.

[52]  I. Schipper,et al.  Use and efficacy of bone morphogenetic proteins in fracture healing , 2011, International Orthopaedics.

[53]  Benjamin M Wu,et al.  High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. , 2011, Tissue engineering. Part A.

[54]  Byung-Soo Kim,et al.  The efficacy of bone morphogenetic protein-2 depends on its mode of delivery. , 2010, Artificial organs.

[55]  N. Baldini,et al.  Recent highlights on bone stem cells: a report from Bone Stem Cells 2009, and not only… , 2010, Journal of cellular and molecular medicine.

[56]  F. O'Brien,et al.  Addition of hydroxyapatite improves stiffness, interconnectivity and osteogenic potential of a highly porous collagen-based scaffold for bone tissue regeneration. , 2010, European cells & materials.

[57]  J. Parvizi.  Chapter 32 – Bone Grafting , 2010 .

[58]  A. Miyawaki,et al.  Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow , 2009, The Journal of experimental medicine.

[59]  R. Guldberg,et al.  In vivo model for evaluating the effects of mechanical stimulation on tissue-engineered bone repair. , 2009, Journal of biomechanical engineering.

[60]  John K. Song,et al.  Recombinant Human Bone Morphogenetic Protein-2-Induced Radiculitis in Elective Minimally Invasive Transforaminal Lumbar Interbody Fusions: A Series Review , 2009, Spine.

[61]  Shawn C. Little,et al.  BMP heterodimers assemble hetero-type I receptor complexes that pattern the DV axis , 2009, Nature Cell Biology.

[62]  R. Cancedda,et al.  Cartilage and bone extracellular matrix. , 2009, Current pharmaceutical design.

[63]  Tomokazu Fukuda,et al.  BMP type I receptor inhibition reduces heterotopic ossification , 2008, Nature Medicine.

[64]  S. Bhang,et al.  Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. , 2008, Biochemical and biophysical research communications.

[65]  D. Mooney,et al.  Biologic augmentation of polymer scaffolds for bone repair. , 2007, Journal of musculoskeletal & neuronal interactions.

[66]  R. Zellweger,et al.  BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONS , 2007, ANZ journal of surgery.

[67]  Haihua Pan,et al.  Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. , 2007, Biophysical journal.

[68]  R. Crystal,et al.  Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. , 2006, Bone.

[69]  S. Kumar,et al.  Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. , 2006, Osteoarthritis and cartilage.

[70]  Mahboob Rahman,et al.  Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Kosher,et al.  Dlx5 is a positive regulator of chondrocyte differentiation during endochondral ossification. , 2002, Developmental biology.

[72]  Jian Q. Feng,et al.  Dentin Matrix Protein 1, a Target Molecule for Cbfa1 in Bone, Is a Unique Bone Marker Gene , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[73]  J. Lane,et al.  Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the Spine , 2002, Spine.

[74]  A. Meunier,et al.  Tissue-engineered bone regeneration , 2000, Nature Biotechnology.

[75]  J. Wozney,et al.  Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. , 1999, Journal of biomedical materials research.

[76]  V. Rosen,et al.  Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.

[77]  S. Bjornsson.  Simultaneous preparation and quantitation of proteoglycans by precipitation with Alcian blue , 1993 .

[78]  M. Hunkapiller,et al.  Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.